Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Case Management Intervention to Prevent ER Visits in HIV-infected Persons

This study has been terminated.
(Intervention was taken up as a standard of care.)
Information provided by (Responsible Party):
University of California, San Francisco Identifier:
First received: September 13, 2005
Last updated: January 21, 2014
Last verified: January 2014
Case management has become an integral part of HIV care. There is little science however demonstrating its effectiveness. This is a randomized, controlled trial of a phone call intervention after an ER visit to see if this can reduce further ER visits, hospitalizations, deaths, and cost.

Condition Intervention
Behavioral: Case manager phone call after an ER visit

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention

Resource links provided by NLM:

Further study details as provided by University of California, San Francisco:

Primary Outcome Measures:
  • Death, hospitalizations, ER visits, LOS [ Time Frame: 1 year ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Cost [ Time Frame: 1 year ] [ Designated as safety issue: No ]

Enrollment: 612
Study Start Date: April 2004
Study Completion Date: January 2013
Primary Completion Date: January 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Intervention
Phone call after an ER visit.
Behavioral: Case manager phone call after an ER visit
No Intervention: Control
No phone call after an ER visit.

Detailed Description:
One year retrospective look at outcome measures followed by a one year trial of a phone call after each ER visit in half of the group. Outcomes measured are cost, ER visits, hospitalizations, death, length of stay. Adults only, English or Spanish, questionnaire on depression, appointments, drug use with referral to case management services, drug rehab services, or followup appointments. Time for intervention is recorded to estimate cost.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patient in our clinic as of 4-1-04

Exclusion Criteria:

  • <18 years old
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00187590

United States, California
University Medical Center
Fresno, California, United States, 93702
Sponsors and Collaborators
University of California, San Francisco
Principal Investigator: Roger B Mortimer, MD UCSF-Fresno Medical Eduction Program
  More Information

Responsible Party: University of California, San Francisco Identifier: NCT00187590     History of Changes
Other Study ID Numbers: UMC200517 
Study First Received: September 13, 2005
Last Updated: January 21, 2014
Health Authority: United States: Food and Drug Administration

Keywords provided by University of California, San Francisco:
case management processed this record on October 20, 2016